Thursday, September 8, 2011

PositiveID Corp. (PSID) Mobile Health System for Diabetes Management Selected by Rogers Communications for Canadian Technology Showcase

PositiveID Corp., a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, today announced that Rogers Communications has included their iglucose mobile health system in the Technology Showcase 2011 that opens today in Toronto and travels through major Canadian cities until October. The annual Rogers Technology showcase is designed to bring together top hardware, software and service vendors in the wireless field so businesses can play with new devices, chat with experts, watch product demos and learn about new solutions that help change the way companies use technology for business.

PositiveID’s iglucose is a revolutionary way for individuals to manage their diabetes as it uses mobile technology to communicate blood glucose readings from glucometers to the iglucose diabetes management portal where the data can then be shared real time with family members, caregivers and healthcare providers. This method eliminates the burdensome task of journaling that often was placed on patients and further increases the data that doctors can use to monitor treatment regimens including medication and patient behavior. With more than 9 million Canadians living with diabetes or pre-diabetes and about 41,500 deaths attributed to complications from diabetes, healthcare professionals are continually seeking the best methods for self-monitoring to try to decrease the expected rising costs associated with diabetes related illness.

Rogers Communications and PositiveID announced a partnership in June for the mobile and machine to machine wireless connectivity of the iglucose system in Canada. Further, PositiveID joined the Rogers Data Alliance program which consists of a consortium of best-in-breed technology companies working together to provide high performance wireless data solutions to corporate and general business customers. PositiveID has also partnered with MobiCare Technologies Inc., a specialized Canadian healthcare products distributor, to launch iglucose in Canada. iglucose has not been cleared for sale in the U.S. by the United States Food and Drug Administration or in Canada by Health Canada.

The Rogers Technology Showcase opened yesterday in Ottawa, travels today to Toronto, and upcoming dates include Vancouver (Sept 16), Calgary (Sept 20), Edmonton (Sept 22), Winnipeg (Oct 5) and Montreal (Oct 13).

For more information on PositiveID, please visit www.PositiveIDCorp.com

About MissionIR:  

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html